JPH0160036B

NEW MATERIAL:The peptide of formulaI(R is H, H-Phe, H-Leu-Gly-Phe-, H- Tyr-Asn-Leu-Leu-Gly-Phe-, or H-Met-Ser-Tyr-Asn-Leu-Leu-Gly-Phe-). USE:Hapten to immunogen. PROCESS:The peptide of formula IV is obtained by the peptide-condensation reaction of the peptide of formula II (A is amino-protecting gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHIMIZU FUMIO, IMAGAWA KENICHI, OOMOTO YASUKAZU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:NEW MATERIAL:The peptide of formulaI(R is H, H-Phe, H-Leu-Gly-Phe-, H- Tyr-Asn-Leu-Leu-Gly-Phe-, or H-Met-Ser-Tyr-Asn-Leu-Leu-Gly-Phe-). USE:Hapten to immunogen. PROCESS:The peptide of formula IV is obtained by the peptide-condensation reaction of the peptide of formula II (A is amino-protecting group; B is OH or active group of carboxyl) with the compound of formula III (C is guanidino- protecting group of arginine) in the presence of a solvent such as DMSO, at -40-+60 deg.C, preferably -20-+40 deg.C. The obtained peptide is reduced with metallic sodium in liquid ammonia at -40--70 deg.C, and the protecting groups A and C are eliminated to obtain the objective peptide of formulaIwherein R is H. The amount of the metallic sodium is adjusted to develop the reaction solution is permanent blue color for 0.5-10min.